By Lance Duroni ( April 12, 2012, 4:24 PM EDT) -- Activist investor Carl Icahn stepped up his pressure Thursday on Amylin Pharmaceuticals Inc. over the company's alleged rejection of a $3.5 billion offer from Bristol-Myers Squibb Co., filing suit to force the drugmaker to open its books and records to shareholders....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.